Clinical Trials in Boston

Showing 4041-4060 of 17,836 trials

Hydroxychloroquine in Outpatient Adults With COVID-19

NCT04333654

Primary Objective: To assess the effect of hydroxychloroquine versus placebo on nasopharyngeal SARS-CoV-2 viral load in outpatient adults with COVID-19 Secondary Objectives: * To assess the effect of hydroxychloroquine versus placebo on clinical signs and symptoms and progression of disease in outpatient adults with COVID-19 * To assess the safety and tolerability of hydroxychloroquine in outpatient adults with COVID-19

Coronavirus Infection

Sanofi8 participantsStarted Apr 2020

Boston, Massachusetts, United States • Brussels, Belgium • Lodelinsart, Belgium +4 more locations

Active Not RecruitingPhase 2< 1 mile

Study of Lenacapavir and Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) in Prevention of HIV in Cisgender Women in the United States (HPTN 102)

NCT06101329

The goal of this clinical study is to look at how lenacapavir (LEN) passes through the body and to assess the safety of LEN and emtricitabine/tenofovir disoproxil fumarate (F/TDF) for prevention of HIV in the cisgender women in the US. The primary objectives of this study are: 1) to characterize the pharmacokinetics (PK) of LEN in United States (US) cisgender women; 2) to evaluate the safety of LEN and F/TDF for pre-exposure prophylaxis (PrEP) in US cisgender women; and 3) to evaluate the general acceptability of LEN injections and oral F/TDF in US cisgender women.

Pre-Exposure Prophylaxis of HIV Infection

Gilead Sciences253 participantsStarted Nov 2023

Birmingham, Alabama, United States • San Diego, California, United States • Washington D.C., District of Columbia, United States +8 more locations

Hydroxychloroquine in Outpatient Adults With COVID-19

Study of Lenacapavir and Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) in Prevention of HIV in Cisgender Women in the United States (HPTN 102)

Find Trials by Condition in Boston

A Study to Investigate the Safety of DSP-3077 After a Unilateral Eye Injection in Male and Female Participants 18 Years of Age or Older With Retinitis Pigmentosa

Beacon Sensors and Telerehabilitation to Assess and Improve Use of Devices (BeST-AID) for Low Vision

Rapid Diagnostic Assay for Gonorrhea and Chlamydia

CAB-AXL-ADC Safety and Efficacy Study in Adult and Adolescent Patients With Sarcoma

Stereotactic Body Radiotherapy (SBRT) for Early Treatment of Oligometastatic Adenoid Cystic Carcinoma: The SOLAR Trial

Treatment of Restless Legs Symptoms With Pramipexole to Improve the Outcomes of Protracted Opioid Withdrawal in OUD

A Patient Registry Study for Patients Treated With Voretigene Neparvovec in US

Predicting the Success of Dry Eye Disease Interventions Using Clinical Tests

Efficacy & Safety Study of Pregabalin to Treat Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS)

Nasal Protollin in Early Symptomatic Alzheimer's Disease

Evaluate the Safety, Efficacy, and Pharmacokinetics of CRN04894 in Participants With Congenital Adrenal Hyperplasia (TouCAHn)

A Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Participants With Acne Vulgaris

A Study of AZD3427 in Participants With Heart Failure and Pulmonary Hypertension Group 2

Imaging Study to Investigate Safety and Diagnostic Performance of 18F rhPSMA 7.3 PET Ligand in Suspected Prostate Cancer Recurrence

Hemiarch vs Extended Arch in Type 1 Aortic Dissection

Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study

Phase 2 Safety and Efficacy Evaluation of AL8326 in ≥2nd Line SCLC

An Extension Study to Evaluate Safety and Efficacy in Participants Treated With CRN04894